[PDF][PDF] MRI 在甲状腺肿瘤的肿块定位和良恶性判断中的应用研究
张书卿， 张裘， 张博， 洪亮， 龙学颖 - 现代生物医学进展, 2015 - biomed.cnjournals.com
… Prognosis of low-risk papillary thyroid carcinoma patients: Its relationship with the size of …
SPECT) in detection of bone metastases of differentiated thyroidcancer: a pilot study [J]. The …
SPECT) in detection of bone metastases of differentiated thyroidcancer: a pilot study [J]. The …
DTC患者经131I治疗后唾液腺损伤的评价及预防
尚康康， 程兵 - 国际放射医学核医学杂志, 2021 - ijrmnm.com
… [Abstract] 131I therapy is a routine adjuvant therapy for patients with differentiated thyroid
carcinoma (DTC) after operation, which can effectively reduce the recurrence rate of the …
carcinoma (DTC) after operation, which can effectively reduce the recurrence rate of the …
[PDF][PDF] 分化型甲状腺癌颈部淋巴结转移相关分子的研究进展
赵小慧， 魏明辉， 李正江， 安常明 - 中国普通外科杂志, 2023 - zpwz.net
… thyroid carcinoma,ATC)占 1.0%;甲状腺岛状癌占0.2%,其中PTC 和FTC 统 称为分化型甲状腺癌
(differentiated thyroid carcinoma,DTC… and low-risk nature of RAS-positive thyroid nodules[J]. …
(differentiated thyroid carcinoma,DTC… and low-risk nature of RAS-positive thyroid nodules[J]. …
[PDF][PDF] 分化型甲状腺癌的动态风险评估——从疾病特点出发的新理念
关海霞， 梁楠 - 中国普通外科杂志, 2016 - zpwz.net
… 过去10年间,分化型甲状腺癌(differentiated thyroid cancer,DTC)的风险评估和临床管理方 法
发生了日新月异的变化,DTC的治疗和随访指 南也趋于个体化和精细化[1-2].准确的风险评估是 …
发生了日新月异的变化,DTC的治疗和随访指 南也趋于个体化和精细化[1-2].准确的风险评估是 …
[PDF][PDF] 甲状腺癌中m6A 甲基化调控因子的表达及其预后价值
王文龙， 沈聪， 孙博韬， 白宁， 李新营， 陈嘉欣， 彭婀敏 - 中国普通外科杂志, 2021 - zpwz.net
… low-risk patients (P=0.007). The ROC analysis indicated a reliable prediction performance of
the model for patients with thyroid cancer (… to distant metastasis in well-differentiated thyroid …
the model for patients with thyroid cancer (… to distant metastasis in well-differentiated thyroid …
[PDF][PDF] 高危分化型甲状腺癌手术及131I 治疗后疗效分类及影响因素分析
周倩， 王瑞华， 刘保平， 韩星敏 - 中华核医学与分子影像杂志, 2021 - chinanm.cma.org.cn
… in patients with high⁃risk differentiated thyroid carcinoma after surgery and 131 I treatment
… classified as low⁃risk again. Female,patients with N0 stage,psTg<5.38 μg/L and tumor size <…
… classified as low⁃risk again. Female,patients with N0 stage,psTg<5.38 μg/L and tumor size <…
血清卵泡抑素联合甲状腺球蛋白对甲状腺癌根治性术后复发的预测价值分析
徐道辉， 林靓宇 - 岭南现代临床外科, 2023 - lingnanwaike.com
… for postoperative recurrence of thyroid cancer,and evaluated the risk factors for radical
recurrence of thyroid cancer. Results The serum FS level and thyroglobulin level in the relapse …
recurrence of thyroid cancer. Results The serum FS level and thyroglobulin level in the relapse …
治疗前刺激性甲状腺球蛋白, 刺激性甲状腺球蛋白和甲状腺球蛋白减少指数对分化型甲状腺癌患者131I 治疗后长期缓解的预测价值研究
何宇， 杨汐， 燕红， 王帅奇 - 中国全科医学, 2020 - chinagp.net
… Correlation between minimal extrathyroid invasion and recurrence in differentiated
thyroid cancer[J].China Oncology,2017,27(12):946-952. DOI:10.19401/j.cnki.1007-3639.2017.12.005…
thyroid cancer[J].China Oncology,2017,27(12):946-952. DOI:10.19401/j.cnki.1007-3639.2017.12.005…
[PDF][PDF] 确诊至手术时间的间隔对甲状腺微小乳头状癌患者临床结局的影响
李莉， 刘晖 - 中国普通外科杂志, 2020 - zpwz.net
… average tumor size of the initial US determination was (0.65±0.12) cm; 214 cases received
thyroid … Active monitoring: first-line treatment of low-risk thyroid micropapillary carcinoma?[J]. …
thyroid … Active monitoring: first-line treatment of low-risk thyroid micropapillary carcinoma?[J]. …
颈内静脉肩胛舌骨肌淋巴结在判断甲状腺乳头状癌侧颈隐匿性转移中的价值
安常明， 王岩， 王世旭， 殷玉林… - Chinese Journal of …, 2017 - search.ebscohost.com
… for patients with low⁃risk papillary thyroid carcinoma measuring 1.1⁃3.0 … Thyroid Association
management guidelines for patients with thyroid nodules and differentiated thyroid cancer…
management guidelines for patients with thyroid nodules and differentiated thyroid cancer…